Fineotex Chemical Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹5,961 Cr
- P/E
- 48.73
- ROE
- 13.48%
- PEG
- 6.80
- Price to sales
- 5.90
- Debt to equity
- 0.01
- 52W high / low
- ₹249 / ₹19.2
- Sales growth (5Y)
- 28.72%
- EBITDA margin
- 16.67%
- Net profit margin
- 16.19%
- Promoter holding
- 62.30%
- Sales (last year)
- ₹1,012 Cr
Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]
Guidance scorecard · Q1 FY27 call
What Fineotex Chem's management guided
and where it ranks in Chemicals & Petrochemicals
Chemicals & Petrochemicals
RevenueQ1 FY27 call
20–40%- Fineotex aims to achieve USD 200 million revenue from CrudeChem (CCT) segment by FY'28, doubling from approx. INR 1,000 crores in FY'26.
- The company expects organic growth aided by sustainability trends and replication of product lines in global markets.
- Texas plant has expanded capacity to 1,48,000 MTPA with current utilization around 63-65%; plans to increase utilization to peak in coming quarters.
- Potential exists to double production by running two shifts with minimal additional capex (~USD 1-2 million).
- Growth driven by increasing wallet share in oil & gas markets across USA, Canada, Venezuela, Gulf countries, Saudi Arabia, and new markets like Suriname and Guyana.
- Textile business expected to recover from seasonal dips; moderate growth aligned with 5-7% industry CAGR.
2 more points from Fineotex Chem's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what Fineotex Chem said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Fineotex Chemicals invested significantly in expanding its Texas facility, adding 69,000 MTPA capacity, increasing total capacity to 268,000 MTPA, enhancing ability to serve larger customer contracts and drive growth.
- The CrudeChem Group acquisition provided growth capital enabling capacity expansion and ramp-up; additional minor capex of USD 1-2 million anticipated for doubling shifts or enhancing capacity.
- Company remains cash disciplined with high cash on book and continues to monitor for selective inorganic growth opportunities with focus on synergy and value.
- Further capital infusion helped secure better pricing from suppliers, improving EBITDA margins.
- No major capex concerns currently; incremental capital investments are relatively small compared to growth potential.
2 more points from Fineotex Chem's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
See what Fineotex Chem said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Rising- There is no traditional "order book" system like government tenders; orders vary with oil and gas cycles.
- Business depends on delivering value as per client needs, with a focus on sustainable solutions.
- Once a well starts production, work is generally perennial and cannot be stopped abruptly.
- The company experiences fluctuations due to weather and operational cycles but maintains steady demand.
- Strong ongoing order flow is indicated, with existing expanded capacities being utilized (~63% utilized recently).
2 more points from Fineotex Chem's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹263 Cr | 3.4 | |
| 2 | 40%+ | Flat | ₹4,375 Cr | 83.7 | |
| 3 | 40%+ | Flat | ₹3,259 Cr | 4.0 | |
| 4 | 40%+ | Flat | ₹145 Cr | 15.9 | |
| 5 | 20–40% | Up 2%+ | ₹1.81L Cr | 90.9 | |
| 6 | 20–40% | Up 2%+ | ₹48,366 Cr | 78.3 |
Sign up free to see every company in the sector ranking and track Fineotex Chem.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Fineotex Chem
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Fineotex Chem
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 138 | 132 | 145 | 138 | 153 | 142 | 146 | 126 | 120 | 137 | 138 | 184 | 314 |
| Expenses + | 105 | 101 | 107 | 98 | 115 | 107 | 109 | 92 | 99 | 112 | 107 | 149 | 270 |
| Operating Profit | 33 | 32 | 38 | 40 | 38 | 35 | 36 | 34 | 21 | 25 | 31 | 35 | 44 |
| OPM % | 24% | 24% | 26% | 29% | 25% | 25% | 25% | 27% | 18% | 18% | 23% | 19% | 14% |
| Other Income + | 2 | 4 | 4 | 5 | 4 | 5 | 7 | 5 | 8 | 9 | 8 | 7 | 9 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 4 |
| Profit before tax | 33 | 34 | 40 | 44 | 40 | 38 | 41 | 36 | 26 | 31 | 35 | 38 | 48 |
| Tax % | 22% | 22% | 22% | 24% | 24% | 22% | 21% | 24% | 24% | 21% | 26% | 21% | 9% |
| Net Profit + | 26 | 26 | 31 | 33 | 30 | 29 | 32 | 28 | 20 | 25 | 26 | 30 | 44 |
| EPS in Rs | 0.23 | 0.23 | 0.28 | 0.29 | 0.27 | 0.26 | 0.28 | 0.24 | 0.17 | 0.22 | 0.23 | 0.23 | 0.27 |
Financials of Fineotex Chem
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 102 | 110 | 127 | 141 | 182 | 196 | 219 | 368 | 517 | 569 | 533 | 772 |
| Expenses + | 85 | 82 | 98 | 111 | 148 | 162 | 178 | 297 | 404 | 421 | 406 | 637 |
| Operating Profit | 16 | 28 | 29 | 30 | 34 | 35 | 41 | 71 | 113 | 148 | 127 | 135 |
| OPM % | 16% | 26% | 23% | 21% | 19% | 18% | 19% | 19% | 22% | 26% | 24% | 17% |
| Other Income + | 5 | 2 | 10 | 5 | 1 | -11 | 17 | 6 | 7 | 17 | 24 | 33 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 13 |
| Profit before tax | 20 | 29 | 38 | 34 | 34 | 22 | 56 | 73 | 115 | 158 | 141 | 153 |
| Tax % | 28% | 31% | 24% | 29% | 28% | 35% | 20% | 22% | 22% | 23% | 23% | 18% |
| Net Profit + | 15 | 20 | 29 | 24 | 24 | 14 | 45 | 57 | 90 | 121 | 109 | 125 |
| EPS in Rs | 0.11 | 0.16 | 0.23 | 0.20 | 0.20 | 0.12 | 0.38 | 0.50 | 0.80 | 1.08 | 0.94 | 0.93 |
| Dividend Payout % | 9% | 13% | 4% | 10% | 5% | 4% | 8% | 8% | 10% | 15% | 8% | 3% |
Financials of Fineotex Chem
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 23 | 116 |
| Reserves | 54 | 69 | 90 | 113 | 137 | 147 | 187 | 240 | 327 | 425 | 708 | 766 |
| Borrowings + | 2 | 3 | 1 | 5 | 2 | 3 | 3 | 2 | 7 | 5 | 0 | 8 |
| Other Liabilities + | 23 | 20 | 26 | 21 | 34 | 35 | 54 | 75 | 67 | 96 | 83 | 269 |
| Total Liabilities | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 1,159 |
| Fixed Assets + | 18 | 19 | 27 | 29 | 36 | 41 | 59 | 84 | 99 | 141 | 179 | 278 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 0 | 0 | 21 | 2 |
| Investments | 29 | 39 | 47 | 55 | 48 | 52 | 32 | 17 | 89 | 147 | 330 | 317 |
| Other Assets + | 54 | 56 | 66 | 77 | 110 | 114 | 171 | 238 | 234 | 260 | 284 | 562 |
| Total Assets | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 1,159 |
Financials of Fineotex Chem
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 14 | 14 | 19 | 6 | 12 | 28 | 9 | 13 | 107 | 97 | 69 | -24 |
| Cash from Investing Activity + | -14 | -13 | -14 | -6 | 5 | -19 | -7 | 1 | -99 | -47 | -273 | 105 |
| Cash from Financing Activity + | -3 | -1 | -6 | -4 | -3 | -4 | -4 | -6 | -6 | -24 | 176 | -63 |
| Net Cash Flow | -3 | -1 | -1 | -3 | 14 | 6 | -2 | 8 | 1 | 26 | -27 | 19 |
| Free Cash Flow | 8 | 12 | 14 | 4 | 4 | 22 | -15 | -9 | 88 | 49 | 1 | -49 |
| CFO/OP | 109% | 84% | 104% | 52% | 63% | 104% | 46% | 43% | 119% | 92% | 77% | -0% |
Financials of Fineotex Chem
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 84 | 84 | 72 | 98 | 100 | 138 | 110 | 72 | 89 | 79 | 137 |
| Inventory Days | 56 | 66 | 70 | 97 | 84 | 66 | 79 | 98 | 53 | 55 | 75 | 109 |
| Days Payable | 75 | 75 | 82 | 50 | 70 | 73 | 101 | 96 | 53 | 79 | 66 | 114 |
| Cash Conversion Cycle | 60 | 75 | 72 | 119 | 112 | 93 | 116 | 111 | 72 | 64 | 88 | 133 |
| Working Capital Days | 58 | 73 | 73 | 114 | 118 | 107 | 136 | 125 | 71 | 76 | 104 | 153 |
| ROCE % | 21% | 31% | 35% | 26% | 22% | 20% | 28% | 30% | 36% | 39% | 24% | 18% |
Guidance history
How Fineotex Chem's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 20–40% | Flat | Planned | — | Rising |
| Q4 FY26 call → | 40%+ | Up 2%+ | Planned | — | Rising |
| Q3 FY26 call → | 20–40% | Flat | Planned | None planned | Rising |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
97 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +132.8% | 96% |
| Last 6 months | +146.7% | 98% |
| Last 3 months | +47.7% | 95% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Fineotex Chem: 0.4 × 96 + 0.4 × 98 + 0.2 × 95 = 97.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 16 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Fineotex Chem's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
- Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
- NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.